Abstract We report the first 3 cases of inflammatory myopathy with abundant macrophages (IMAM) to be found in an Asian country. Diagnosis of IMAM was based on the infiltration of CD68? macrophages into biopsied specimens, particularly the fascia. Proximal skeletal muscle symptoms and signs, elevation of creatine kinase, and myogenic changes in electromyography were found in all of the cases, and magnetic resonance imaging clearly revealed thickening of the fascia. Since dermatomyositis (DM)-specific skin alterations were not
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Introduction
In addition to the classical inflammatory myopathies, i.e., polymyositis, dermatomysitis (DM), and inclusion body myositis, the spectrum of inflammatory myopathies also includes inflammatory myopathy with a predominance of macrophages in the tissues, i.e., macrophagic myofasciitis (MMF) [1] , and inflammatory myopathy with abundant macrophages (IMAM) [2] [3] [4] . MMF is a unique, unusual inflammatory myopathy, initially described in 14 adult patients from France [5] . The characteristic pathology of MMF in muscle biopsies involves infiltration of macrophages with lymphocytes into deep subcutaneous fat, epimysium, perimysium, and endomysium [1, 6] . The activation of macrophages in MMF is caused by persistent immune activation following intramuscular injection of aluminum hydroxide-containing vaccines, especially in focal cases [6] [7] [8] . On the other hand, IMAM is unrelated to aluminum hydroxide-adjuvanted vaccines and is characterized by scaly DM-like or atypical non-DM-like skin alterations and proximal muscle weakness, thus leading to the clinical diagnosis of DM, atypical systemic lupus erythematosus, or overlap syndrome [2] [3] [4] . In MMF, macrophage infiltrates are restricted to the presumed site of previous immunization; however, diffuse destructive infiltration of macrophages into the fascia, rather than the muscle, is characteristic of IMAM [2] [3] [4] . A relationship and even a continuum between DM and IMAM have been suggested in a case report [3] ; however, it remains unclear whether IMAM is distinct from DM. This is the first report of IMAM in an Asian country. Furthermore, this report contains new information regarding myositis-specific autoantibodies and magnetic resonance imaging (MRI) of the affected tissues in patients with IMAM.
Case report Table 1 summarizes the demographics of the 3 individual cases. In all cases, there was systemic myalgia and elevated creatine kinase (CK); however, DM-specific skin alterations, including heliotrope erythema, Gottron's papules, and Gottron's signs, were not detected. None of the cases fulfilled Bohan and Peter's criteria for DM [9, 10] . The patients had not received vaccines containing aluminum hydroxide. The diagnosis of IMAM was based on infiltration of CD68? macrophages into the muscle specimens that were biopsied ( Fig. 1 ). In addition, thickening of the fascia was identified in all of the biopsied specimens ( Fig. 1a-i) . A number of CD68? macrophages associated with CD4? T lymphocytes ( Fig. 1d ), CD8? T lymphocytes ( Fig. 1e) , and CD20? B cells ( Fig. 1f) were found in the fascia, whereas very few inflammatory cells were detected in the muscle tissue. Figure 2a -c show short-time inversion recovery (STIR; TR 3000, TE 12, T1 160) images from a plain MRI of the affected muscles. Thickening of the fascia was clearly demonstrated by MRI, whereas STIR high lesions were not as obvious in the muscle tissue. These alterations shown by MRI reflect similar changes that were identified from our histological analyses. Myogenic change with fibrillation of the affected muscles on needle electromyogram was determined in all 3 cases (data not shown). Analysis of myositis-specific autoantibodies including anti-aminoacyl tRNA synthetase (ARS), anti-clinically amyopathic dermatomyositis-140-kD polypeptide (anti-CADM-140-kD Abs), and anti-155/140-kD polypeptide (anti-155/140-kD Abs) was performed in the present cases, according to our recent reports [11, 12] . As shown in Fig. 2e , anti-PL-7 antibody (Ab) was detected in the sera of case 1, whereas none of the other myositis-specific Abs were found in any of the 3 cases. Anti-U1 RNP Ab was detected in case 3 (Fig. 2e) .
The clinical course of case 1, which was complicated with cytophagic histiocytic panniculitis (CHP) of both the upper and lower extremities, as diagnosed by clinical examination and skin biopsy, is briefly described. High serum fibrin degradation products (171 lg/ml), D-dimer (131.4 lg/ml), and ferritin (12,786 ng/ml; normal range, 4.0-87.0 ng/ml) were observed at the time of admission.
A computed tomography (CT) scan of the chest showed diffuse consolidation and ground glass opacities throughout both lungs (Fig. 2d) . Cell findings of bronchoalveolar lavage fluid revealed a normal appearance, but increased neutrophils (30%) and lymphocytes (25%), which are suggestive of a pattern of diffuse alveolar damage, were also observed. The bone marrow smear showed normal cellularity with several hemophagocytic macrophages. Thus, in addition to CHP, this patient was considered to suffer from macrophage activation syndrome (MAS) and acute respiratory distress syndrome (ARDS). (This case met the diagnostic criteria for MAS [13] as well as ARDS [14] .) Intensive combination therapy, including plasmapheresis (four times), leukocytapheresis (two times), polymyxin B-immobilized fiber direct hemoperfusion (once), pulse methylprednisolone (four times after referral, for a total of six times), sivelestat sodium, an inhibitor of human neutrophil elastase (250 mg/day for 14 days), and oral administration of immunosuppressants (tacrolimus at first, changed to cyclosporine A), was initiated. These therapies were highly effective, and most of the above abnormalities were resolved within 2 weeks. High serum tumor necrosis factor a (TNF-a), soluble TNR receptor 1 (sTNFR1), and sTNFR2 levels were determined before the treatment [TNF-a = 131.8 pg/ml (11.9 ± 6.4 pg/ml in 16 healthy controls), sTNFR1 = 7.0 ng/ml (1.2 ± 1.1 ng/ml in 13 healthy controls), sTNFR2 = 30.9 ng/ml (3.0 ± 1.3 ng/ml in 13 healthy controls)], and 2 weeks later, these levels had decreased dramatically (TNF-a decreased to 20.7 pg/ml, sTNFR1 decreased to 4.2 ng/ml, and sTNFR2 decreased to 14.8 ng/ml).
Spontaneous remission did not occur in case 2 or case 3, and so glucocorticoid administration was required to achieve remission in these cases (Table 1) .
Discussion
This is the first report of IMAM in Asian countries, including a severe case of complicated MAS and ARDS that was successfully treated.
First, IMAM that resembled DM was recently reported in several European countries [2] [3] [4] . Our 3 cases represent the first report of IMAM in an Asian country. All of our cases showed proximal skeletal muscle symptoms and signs as well as elevation of CK; however, they did not fulfill Bohan and Peter's criteria for DM [9, 10] . The thickening of the fascia and inflammatory infiltrates, predominantly at the periphery of muscle fascicles, was found histologically in our cases. This is different from DM where inflammatory infiltrates are predominantly located perivascularly in the perimysium [6] . These findings are consistent with previous reports that IMAM is sometimes defined clinically as atypical DM [2] [3] [4] .
Second, the diagnostic sensitivity and availability of MRI for IMAM has not been evaluated. It is interesting to note that our present 3 cases show the efficacy of plain MRI for identifying the thickening of the fascia, which reflects our histological findings to a large extent. Characteristic MRI in DM patients consists of a multifocal or diffuse pattern of high signal intensity on STIR or non-fatsaturated sequences in proximal limb muscles [15, 16] . Guis et al. reported that no particular MRI abnormality was observed in MMF [17] . These observations suggest that STIR images are useful for the differential diagnosis of DM, MMF, and IMAM. Plain MRI is a non-invasive method; thus, we recommend plain MRI for the early recognition of IMAM.
Third, Brunn et al. compared the cellular subset in affected tissues in IMAM with DM [4] . They found less infiltration of B cells and plasmatoid dendritic cells but more infiltration of TNF-a-producing cells in IMAM than in DM [4] . Brunn et al. explained that these differences may reflect the two stages of one disorder or two distinct disease entities. We evaluated our 3 cases from this point of view. Screening of myositis-specific autoantibodies of anti-ARS antibodies, anti-CADM-140-kD Abs, and anti-155/140-kD Abs was performed in all 3 cases, which represents the first time such a study of IMAM has been done. The similarity of IMAM in our cases with DM was suspected because case 1 expresses anti-PL-7 Ab and because infiltration of B cells into the fascia was found in all 3 cases. The difference in B-cell infiltration into the fascia in patients with IMAM could be due to racial differences of the studied population. Yamasaki et al. examined the characteristics of anti-PL-7 Ab-positive DM patients in the Japanese population and reported that these patients show milder skeletal muscle involvement when compared with anti-Jo-1 Ab-positive patients [18] , again suggesting the development of atypical DM in case 1.
Finally, IMAM shares striking similarities with the so-called cytophagic histiocytic panniculitis (CHP), a condition first recognized by Alegre and Winkelmann [19] , and subsequently reported with increasing frequency in the literature [20] . This condition is characterized by diffuse subcutaneous lobular panniculitis composed of macrophages that show hemophagocytic activity with the presence of T lymphocytes and may develop into macrophage activation syndrome (MAS) manifested by fever, splenomegaly, coagulopathy, and pancytopenia [13, 21] . In this study, severe illness occurred in case 1 due to MAS, which is consistent with a previous report where an IMAM patient died due to hemophagocytic syndrome and disseminated intravascular coagulopathy [2] . An explanation for the striking clinical features and laboratory findings in MAS could be the widespread dissemination of hyperactivated lymphocytes and macrophages and the compatibility of these features with the biologic effects of certain T lymphocyte-and macrophage-derived proinflammatory cytokines such as TNF-a, IL-1, IL-6, and interferon-c [21, 22] . High serum levels of sTNFR1 and sTNFR2 may also reflect MAS since both are produced from TNF-a-stimulated cells [23] . High serum concentrations of TNF-a, sTNFR1, and sTNFR2 were detected in case 1 before treatment, but they decreased rapidly as a result of intensive combination therapy. When compared with other autoimmune diseases, including rheumatoid arthritis, Sjögren's syndrome, and DM [24] , serum levels of TNF-a, sTNFR1, and sTNFR2 in case 1 before treatment were significantly high. Bassez et al. have stated that the hemophagocytic phenomenon in patients with IMAM ranged from clinically asymptomatic hemophagocytosis to lethal MAS [2] . This indicates that macrophages are critically involved in the pathologic process of IMAM and could be useful in determining disease progression. On the other hand, Yajima et al. reported hemophagocytic syndrome in DM patients who had significantly high serum soluble IL-2 receptor, macrophage colony stimulating factor, and chemokine CX3CL1 [25] . The triggering of MAS might be comparable both in IMAM and DM. Further clinical evaluations, for either case, are necessary to answer these questions.
